Failure of single-dose kinetics to predict steady state.

Abstract

1. MONTGOMERY AB, DEBS RJ, LUCE JM, et aJ. Aerosolized pentamidine as sole therapy for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Lancet 1987;2:480-3. 2. GOLDEN JA, HOLLANDERH, CONTE JE, Jr. Inhaled pentamidine or low-dose intravenous pentamidine as novel therapy for Pneumocystis carinii pneumonia (PCP) in the acquired immunodeficiency syndrome (AIDS) (abstract). Am Rev Respir Dis 1987;135:AI68. 3. MONTGOMERY AB, DEBSRC, LUCE JM, et aJ. Concentration of pentamidine in bronchoalveolar lavage fluid after aerosol and intravenous administration (abstract). Am Rev Respir Dis 1987; 135:AI67. 4. DEBSRJ, BLUMENFELDW,BRUNETTEEN, et aJ. Successful treatment with aerosolized pentamidine of Pneumocystis carinii pneumonia in rats. Antimicrob Agents Chemother 1987;31:3741. 5. DEBS RJ, STRAUBINGER RM, BRUNETTE EN, et aJ. Selective enhancement of pentamidine uptake in the lung by aerosolization and delivery of liposomes. Am Rev Respir Dis 1987; 135:731-7. 6. CONTE JE, HOLLANDER H, GOLDEN JA. Inhaled or reduceddose intravenous pentamidine for Pneumocystis carinii pneumonia. Ann Intern Med 1987;107:495-8. 7. MONTGOMERY AB, CORKERYKJ. Protocol for aerosolization of pentamidine for treatment and prevention of Pneumocystis carinii pneumonia in patients with AIDS. University of California, San Francisco, California, 1987. 8. Package insert. Pentam 300 (pentamidine isethionate). Melrose Park, IL: LyphoMed, Inc., 1987.